ESTRACE

This brand name is authorized in United States. It is also authorized in Canada.

Active ingredients

The drug ESTRACE contains one active pharmaceutical ingredient (API):

1	Estradiol UNII 4TI98Z838E - ESTRADIOL
	Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy.
	Read more about Estradiol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ESTRACE Tablet	MPI, US: SPL/Old	FDA, National Drug Code (US)
ESTRACE Cream	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03CA03	Estradiol	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03C Estrogens → G03CA Natural and semisynthetic estrogens, plain
Discover more medicines within G03CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02148587, 02148595, 02225190
US	FDA, National Drug Code	0430-0720, 0430-0721, 0430-0722, 0430-3754, 50090-2321